Who owns ARS Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SPRY from SEC Form 13F filings across 187 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 187 institutions disclosed 88.5M shares of ARS Pharmaceuticals, Inc. worth $381.5M — about 88.8% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
187
13F holders
$381.5M
value, 2026 filers
88.8%
of shares outstanding (88.5M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SPRY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 10.9M | $46.8M | 0.5% | 10.9% | 0.0% |
| 2 | Rubric Capital Management LP | 8.5M | $36.8M | 0.3% | 8.6% | 0.0% |
| 3 | ORBIMED ADVISORS LLC | 8.3M | $35.7M | 0.6% | 8.3% | 0.0% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 7.5M | $32.3M | 0.5% | 7.5% | 0.0% |
| 5 | BlackRock, Inc. | 5.6M | $24.1M | 0.0% | 5.6% | +5.1% |
| 6 | SR ONE CAPITAL MANAGEMENT, LP | 4.0M | $17.3M | 1.5% | 4% | 0.0% |
| 7 | STATE STREET CORP | 3.7M | $15.9M | 0.0% | 3.7% | -1.1% |
| 8 | UBS Group AG | 3.7M | $15.8M | 0.0% | 3.7% | +88.9% |
| 9 | MILLENNIUM MANAGEMENT LLC | 3.3M | $14.1M | 0.0% | 3.3% | +36.2% |
| 10 | Tyro Capital Management LLC | 3.2M | $13.8M | 2.4% | 3.2% | -28.2% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $10.8M | 0.0% | 2.5% | -2.0% |
| 12 | Capital World Investors | 2.0M | $8.5M | 0.0% | 2% | -28.8% |
| 13 | Aberdeen Group plc | 1.7M | $7.3M | 0.0% | 1.7% | -59.2% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $6.9M | 0.0% | 1.6% | -5.9% |
| 15 | Janney Montgomery Scott LLC | 1.5M | $6.7M | 0.0% | 1.5% | -25.3% |
| 16 | Creek Drive Management Group LLCNEW | 1.1M | $4.8M | 1.3% | 1.1% | new |
| 17 | CITADEL ADVISORS LLC | 1.1M | $4.6M | 0.0% | 1.1% | +103.2% |
| 18 | Third Point LLC | 1.0M | $4.3M | 0.1% | 1% | 0.0% |
| 19 | GENERAL AMERICAN INVESTORS CO INC | 908,428 | $3.9M | 0.2% | 0.9% | -19.8% |
| 20 | K2 PRINCIPAL FUND, L.P. | 662,026 | $2.9M | 0.2% | 0.7% | +76.5% |
| 21 | Pavaki Capital Management LLC | 659,600 | $2.8M | 1.0% | 0.7% | +13.8% |
| 22 | Trexquant Investment LP | 600,077 | $2.6M | 0.0% | 0.6% | +109.3% |
| 23 | Tejara Capital Ltd | 589,042 | $2.5M | 1.2% | 0.6% | -3.0% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 575,372 | $2.5M | 0.0% | 0.6% | +1.5% |
| 25 | ADAR1 Capital Management, LLC | 560,999 | $2.4M | 0.1% | 0.6% | -6.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.